John Hovanesian (Harvard Eye Associates, Laguna Hills, CA, USA) discusses challenges in the intraocular lens (IOL) market, some of the exciting IOLs to have emerged recently, and his thoughts on choosing the best option for patients and the responsibility of the ophthalmic surgen.
1. Could you briefly introduce yourself and give us an overview of the current challenges of the premium intraocular lens (IOL) market? (0.05)
2. What are the most exciting premium IOLs to have emerged recently? (0.56)
3. With an increasing range of premium IOLs available, how does the physician choose between them? (3.07)
4. In this expanded treatment landscape, what is the responsibility of the ophthalmic surgeon? (4.11)
Disclosures: John A Hovanesian has provided paid consultancy for 1-800-DOCTORS, Acufocus, Aerie Pharmaceutical, Alcon, Allegro Ophthalmics, Allergan, Abbott Medical Optics, BlephEx, Eyedetec, Glaukos, Guardion Health Sciences, IOP/Katena, Ivantis, Kala Pharma, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Sarentis ophthalmics, Sensimed, Shire, Tearlab, Tear Film Innovations, Valeant, Veracity and Vindico Medical Education. He has served on medical advisory boards for 1-800-DOCTORS, Aerie Pharmaceutical, Abbott Medical Optics, BlephEx, Cord, LLC, Eyedetec, Glaukos, Guardion Health Sciences, Ingenoeye, IOP/Katena, Ivantis, Kala Pharma, MDbackline, Ocular Therapeautix, Omeros, ReVision Optics, Shire, Sight Sciences, Tearlab, Tear Film Innovations, Valeant and Veracity. He has conducted paid research for Acufocus, Aerie Pharmaceutical, Alcon, Allergan, Abbott Medical Optics, Cloudbreak Therapeutics, Cord, LLC, Eyedetec, Glaukos, Ingenoeye, IOP/Katena, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Tear Film Innovations and Valeant. He also has equity interest in Alcon, Alicia Surgery Center, Allegro Ophthalmics, Allergan, BlephEx, Eyedetec, Glaukos, Guardion Health Sciences, Harvard Eye Associates, Harvard Hearing, Ingenoeye, MDbackline, Novartis, Ocular Therapeutix, RxSight, Sarentis Ophthalmics, Sight Sciences and Tear Film Innovations. He has received royalties from sales from Slack Books and TLC The Laser Center. No financial interest exists for prescribing, recommending, or using a particular product in patient care. This list may not be complete because of financial interests that may arise between updates to this document or stock ownership through mutual funds, exchange traded funds, or other vehicles that do not involve a direct relationship with the entity.
Commissioned, edited and funded by Touch Medical Media
Published: 23 June 2020
Share this Video
Related Videos In Refractive Surgery
Deepinder K Dhaliwal, AAO 2020 – Myopia Options in a 50-year-old Myope
We were delighted to speak with Deepinder K Dhaliwal (University of Pittsburgh School of Medicine, Pittsburgh, PA, USA) about her refractive surgery panel at AAO 2020, discussing a case of a 50-year-old -8.00D myope, and the issues and recommendations for treatment. Questions Could you give us a brief overview of the case; who were the […]
Dan Z Reinstein, ESCRS 2020 – Lenticule Extraction or Implantation for Hyperopia
Prof. Dan Z Reinstein (London Vision Clinic, London, UK) talked us through his presentation at ESCRS on lenticule extraction or implantation for hyperopia: what will be the future? Questions Could you briefly introduce yourself and the topic you are presenting? (00:07) Could you tell us a little about the history of lenticule extraction and implantation? […]
Noel Alpins, ESCRS 2020 – Treatment of Astigmatism Using Vector Planning Paradigm
It was a pleasure to catch up with Prof. Noel Alpins (Department of Ophthalmology, Melbourne University, Melbourne, Australia), as he discussed the major challenges of refractive surgery in the treatment of astigmatism, and the evidence for the use of Vector Planning in clinical practice. Questions What are the major challenges of refractive surgery in the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!